| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000036525 |
| Receipt No. | R000041478 |
| Scientific Title | Multicentre prospective observational study protocol for radiation exposure from gastrointestinal fluoroscopic procedures |
| Date of disclosure of the study information | 2019/05/01 |
| Last modified on | 2021/03/10 (Ver. 15) |
| Basic information | ||
| Public title | Multicentre prospective observational study protocol for radiation exposure from gastrointestinal fluoroscopic procedures | |
| Acronym | REX-GI study | |
| Scientific Title | Multicentre prospective observational study protocol for radiation exposure from gastrointestinal fluoroscopic procedures | |
| Scientific Title:Acronym | REX-GI study | |
| Region |
|
|
| Condition | ||||
| Condition | The image guided procedures under fluoroscopic guidance
in the field of gastroenterology. |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To assess the actual radiation exposure dose of the imageguided procedures in the field of gastroenterology (ERCP, I
nterventional-EUS, enteral SEMS, ileus tube, and balloon-a ssisted endoscopy) |
| Basic objectives2 | Others |
| Basic objectives -Others | To evaluate the factors affecting the actual radiation expos
ure dose |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase IV |
| Assessment | |
| Primary outcomes | Radiation exposure dose (Air Kerma (AK) and Dose Area
product (DAP)) and fluoroscopy time of each procedure. |
| Key secondary outcomes | To evaluate the actual radiation exposure dose (RD) and th
e following factors. Exposure field of the fluoroscopy, Frame rate, Frequency o f Xray, Factors of each image-guided procedures (ERCP, Interventional EUS, enteral SEMS, ileus tube), Type of disease, treatment and scope, Procedure time, Anesthesia |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients who need image guided procedures under fluoroscopic guidance in the field of gastroenterology under usual clinical care. | |||
| Key exclusion criteria | All patients reject to participate in this study via the opt-out method. | |||
| Target sample size | 5000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Toyonaka Municipal Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 560-8565 | ||||||
| Address | 4-14-1 Shibahara, Toyonaka, Osaka | ||||||
| TEL | 06-6843-0101 | ||||||
| tnishida.gastro@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Toyonaka Municipal Hospital | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 560-8565 | ||||||
| Address | 4-14-1 Shibahara, Toyonaka, Osaka | ||||||
| TEL | 06-6843-0101 | ||||||
| Homepage URL | https://www.chp.toyonaka.osaka.jp/aboutus/kenkyuu/index.html | ||||||
| tnishida.gastro@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Gastroenterology,
Toyonaka Municipal Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Japanese Society of Gastroenterology |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Toyonaka Municipal Hospital |
| Address | 4-14-1 Shibahara, Toyonaka, Osaka |
| Tel | 06-6843-0101 |
| tnishida.gastro@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 市立豊中病院(大阪府), 近畿大学付属病院(大阪府) 東京大学医学部付属病院(東京都)、福井県立病院(福井県)、関西労災病院(兵庫県)、大阪市立大学医学部附属病院(大阪府)、石川県立中央病院(石川県)、斗南病院(北海道)、がん研有明病院(東京都)、市立吹田市民病院(大阪府)、大阪労災病院 (大阪府)、 大阪急性期・総合医療センター (大阪府) 、福島県立医科大学附属病院(福島県)、兵庫県立がんセンター(兵庫県)、北野病院(大阪府)、多根総合病院(大阪府)、日本赤十字社医療センター(東京都)、国立病院機構呉医療センター (広島県)、名古屋市立大学大学院(愛知県)、東邦大学医療センター大橋病院(東京都)、大阪国際がんセンター(大阪府)、岐阜大学医学部附属病院(岐阜県)、東邦大学医療センター大橋病院(東京)、大阪国際がんセンター(大阪)、岐阜大学医学部附属病院(岐阜)、順天堂大学医学部付属医院順天堂医院(東京)
|
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://bmjopen.bmj.com/content/10/2/e033604 |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 12416 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Study design: Multi-center prospective observational study.
We examined the procedure time (min), total fluoroscopy time (min), radiation dose (mGy), radiation dose rate (RDR, mGy/min), and dose area product: DAP (mGycm2) during the following procedures. 1) ERCP 2) Interventional EUS 3) Balloon Enteroscopy 4) Enteral Metallic Stent 5) Enteral Long Tube |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041478 |